About
Team
Portfolio
News
Contact
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies
May 28, 2021
|
In
Portfolio Company News
|
By
usvpAdminer
Prev
Next
Cookies are used on our website. Press Accept if you consent to the use of cookies, press Decline if you do not consent to the use of cookies.
Accept
Decline